- Currently associated as the Chairperson Radiation Oncology department of Medanta Hospital, Gurgaon.
- He has expertise in the treatment of Coronary Angioplasty, Rotablation, IVUS, FFR, OCT, and Transcatheter Aortic Valve Replacement (TAVR).
- His interest lies in Heart failure management, structural heart disease interventions like percutaneous valve interventions (TAVI), Para-valvular leak closure, PTSMA & BMV, Cardiac imaging (FFR, OCT, IVUS), LA appendage ligation, aortic interventions like EVAR for aortic aneurysm, Pacemaker, ICD, CRT, COMBO device & percutaneous ECMO implantation.
Dr. Nagendra Singh Chauhan
- Interventional Cardiologist
- Associate Director , MD, DNB, Fellowship 20 years of experience
- Medanta - The Medicity Hospital
- Gurgaon
Dr. Nagendra Singh Chauhan
- Interventional Cardiologist
- Associate Director , MD, DNB, Fellowship 20 years of experience
- Medanta - The Medicity Hospital
- Gurgaon
Profile (Overview)
Specialities
Specialization
- Coronary Artery Disease (CAD) Heart Valve Disease Aortic Aneurysm Aortic Aneurysm Repair Coronary Angioplasty & Stenting Coronary Artery Bypass Grafting (CABG) Heart Failure Heart Transplant Heart Valve Repair Heart Valve Replacement Peripheral vascular disease Stenting Angioplasty
Work Experience of Dr. Nagendra Singh Chauhan
- Associate Director, Medanta – The Medicity, Gurgaon
Education
- , R.N.T. Medical College, Udaipur
- MD, R.N.T. Medical College, Udaipur
- DNB, National Board of Examinations, New Delhi
- Fellowship, Max Heart & Vascular Institute
Awards
- – Best case award in NIC, 2016
Paper Published
- – AXIOM Innovations, Issue 17,34-35. : CLEAR Visualization of stent placement, December 2013
- – Indian Heart Journal 64(6):547-52,81 -82 : A First- In- Man Study of Sirolimus-Eluting, Biodegradable Polymer Cobalt-Chromium Stent (Supralimus-Core®) at Max DDHV Institute in Real Life Patients., November 2012
- – AXIOM Innovations, Issue 17,34-35. : CLEAR Visualization of stent placement, December 2013
- – Indian Heart Journal 64(6):547-52,81 -82 : A First- In- Man Study of Sirolimus-Eluting, Biodegradable Polymer Cobalt-Chromium Stent (Supralimus-Core®) at Max DDHV Institute in Real Life Patients., November 2012
- – In Press: Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements, 2012
